Topics

Diffuse midline glioma | Treatment | Immunotherapy | Overview

Home > Publications > Topics > Diffuse midline glioma > Treatment > Immunotherapy > Overview

Lin C, Smith C, Rutka J.
Current immunotherapeutic approaches to diffuse intrinsic pontine glioma.
Front Genet. 2024 May 7;15:1349612. doi: 10.3389/fgene.2024.1349612. PMID: 38774284. Review. ˍ

Liu J, Ha JH, Abikenari M, Sjoholm MA, Annagiri S, Ravi K, Bergsneider BH, Verma R, Theodros D, Medikonda R, Li G, Prolo LM, Monje M, Lim M.
Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron-glioma interactions, and tumor microenvironment modulation.
J Neurooncol. 2025 Dec 29;176(2):144. doi: 10.1007/s11060-025-05347-9. PMID: 41460355. Review. ˍ

Ramsoomair CK, Sarmiento F, Ramsoomair D, Daftari M, He J, Glazer B, Monje M, Reinberg D, Shah AH.
Deciphering the tumor microenvironment and role of immunotherapy in Diffuse Midline Glioma: a scoping review.
Neuro Oncol. 2026 Feb 2:noag014. doi: 10.1093/neuonc/noag014. PMID: 41629217. Review. ˍ

Kordowski A, Pomaville M, Foster JB, Vitanza NA.
Immunotherapy for Diffuse Midline Glioma: From Preclinical Modeling to Clinical Translation.
Cancers (Basel). 2026 Jul 27;18(15):2411. doi: 10.3390/cancers18152411. PMID: 42588630. ˍ